#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A Gene Expression Signature for RSV: Clinical Implications and Limitations


article has not abstract


Vyšlo v časopise: A Gene Expression Signature for RSV: Clinical Implications and Limitations. PLoS Med 10(11): e32767. doi:10.1371/journal.pmed.1001550
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001550

Souhrn

article has not abstract


Zdroje

1. NairH, SimoesEA, RudanI, GessnerBD, Azziz-BaumgartnerE, et al. (2013) Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet 381: 1380–1390.

2. OpenshawPJ, ChiuC (2013) Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol 3: 468–474.

3. NairH, NokesDJ, GessnerBD, DheraniM, MadhiSA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545–1555.

4. FalseyAR (2007) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 28: 171–181.

5. LeeN, LuiGC, WongKT, LiTC, TseEC, et al. (2013) High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57: 1069–1077.

6. BlankenMO, RoversMM, MolenaarJM, Winkler-SeinstraPL, MeijerA, KimpenJL, et al. (2013) Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 368: 1791–1799.

7. TurchinovichA, SamatovTR, TonevitskyAG, BurwinkelB (2013) Circulating miRNAs: cell-cell communication function? Front Genet 4: 119.

8. McNamaraPS, FlanaganBF, BaldwinLM, NewlandP, HartCA, et al. (2004) Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis. Lancet 363: 1031–1037.

9. JanssenR, BontL, SiezenCL, HodemaekersHM, ErmersMJ, et al. (2007) Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 196: 826–834.

10. WelliverTP, GarofaloRP, HosakoteY, HintzKH, AvendanoL, et al. (2007) Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis 195: 1126–1136.

11. KristjanssonS, BjarnarsonSP, WennergrenG, PalsdottirAH, ArnadottirT, et al. (2005) Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol 116: 805–811.

12. MunirS, HillyerP, LeNC, BuchholzUJ, RabinRL, et al. (2011) Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog 7: e1001336 doi:10.1371/journal.ppat.1001336

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2013 Číslo 11
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#